Show simple item record

dc.contributor.authorBryant, RA
dc.contributor.authorCreamer, M
dc.contributor.authorO'Donnell, M
dc.contributor.authorSilove, D
dc.contributor.authorMcFarlane, AC
dc.date.available2014-05-21T20:38:19Z
dc.date.available2008-10-27
dc.date.available2008-10-27
dc.date.available2008-10-27
dc.date.available2008-10-27
dc.date.available2008-10-27
dc.date.available2008-10-27
dc.date.available2008-10-27
dc.date.available2008-10-27
dc.date.available2008-10-27
dc.date.issued2009-03-01
dc.identifierpii: S0006-3223(08)01321-8
dc.identifier.citationBryant, R. A., Creamer, M., O'Donnell, M., Silove, D. & McFarlane, A. C. (2009). A Study of the Protective Function of Acute Morphine Administration on Subsequent Posttraumatic Stress Disorder. BIOLOGICAL PSYCHIATRY, 65 (5), pp.438-440. https://doi.org/10.1016/j.biopsych.2008.10.032.
dc.identifier.issn0006-3223
dc.identifier.urihttp://hdl.handle.net/11343/27646
dc.descriptionC1 - Journal Articles Refereed
dc.description.abstractBACKGROUND: To index the extent to which acute administration of morphine is protective against development of posttraumatic stress disorder (PTSD). METHODS: Consecutive patients admitted to hospital after traumatic injury (n=155) were assessed for current psychiatric disorder, pain, and morphine dose in the initial week after injury and were reassessed for PTSD and other psychiatric disorders 3 months later (n=120). RESULTS: Seventeen patients (14%) met criteria for PTSD at 3 months. Patients who met criteria for PTSD received significantly less morphine than those who did not develop PTSD; there was no difference in morphine levels in those who did and did not develop major depressive episode or another anxiety disorder. Hierarchical regression analysis indicated that PTSD severity at 3 months was significantly predicted by acute pain, mild traumatic brain injury, and elevated morphine dose in the initial 48 hours after trauma, after controlling for injury severity, gender, age, and type of injury. CONCLUSIONS: Acute administration of morphine may limit fear conditioning in the aftermath of traumatic injury and may serve as a secondary prevention strategy to reduce PTSD development.
dc.formatapplication/pdf
dc.languageEnglish
dc.publisherELSEVIER SCIENCE INC
dc.subjectPsychiatry (incl. Psychotherapy); Clinical Pharmacology and Therapeutics; Mental Health
dc.titleA Study of the Protective Function of Acute Morphine Administration on Subsequent Posttraumatic Stress Disorder
dc.typeJournal Article
dc.identifier.doi10.1016/j.biopsych.2008.10.032
melbourne.peerreviewPeer Reviewed
melbourne.affiliationThe University of Melbourne
melbourne.affiliation.departmentPsychiatry
melbourne.source.titleBIOLOGICAL PSYCHIATRY
melbourne.source.volume65
melbourne.source.issue5
melbourne.source.pages438-440
dc.research.codefor110319
dc.research.codefor111502
dc.research.codeseo2008920410
melbourne.publicationid131648
melbourne.elementsid314154
melbourne.contributor.authorCreamer, Mark
melbourne.contributor.authorO'Donnell, Meaghan
dc.identifier.eissn1873-2402
pubs.acceptance.date2008-10-27
melbourne.accessrightsThis item is currently not available from this repository


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record